Quince Therapeutics, Inc.·4

Feb 11, 5:44 PM ET

Thye Dirk 4

4 · Quince Therapeutics, Inc. · Filed Feb 11, 2025

Insider Transaction Report

Form 4
Period: 2025-01-28
Thye Dirk
DirectorCEO and CMO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-28+1,200,0001,200,000 total
    Exercise: $1.60Exp: 2035-01-27Common Stock (1,200,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2025, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.

Documents

1 file
  • 4
    form4-02112025_100234.xmlPrimary